Dutch woman dies after coronovirus reinfection

Researchers reported that a 89-year-old Dutch-type woman suffering from bone marrow cancer died after being infected with COVID-19 for the second time. The woman, who was not identified in the case report, had previously tested positive for coronavirus after going to the emergency room for a severe cough and fever.

According to the report, which was published by Oxford University Press, the woman was discharged after five days with fatigue. About two months later, she began a new chemotherapy treatment for Waldenstrom’s treatment of macroglobulinemia. Two days later, 59 days after his first COVID-19 diagnosis, he developed fever, cough, and difficulty or difficulty breathing. He was tested again for COVID-19 and a nasal inflammation came back positive.

First US government recruited in America

He was tested twice for the SARS-CoV-2 antibody, but both tests came negative. On day 8 of her reconstruction, her condition worsened and she died two weeks later.

“Our patient was immunized, because Waldenström’s macroglobulinemia was treated with B-cell-deflating therapy, resulting in an abusive immune decline,” the researchers wrote. “However, it was shown that B-cell-defiling therapy does not necessarily produce results [a] Life-threatening disease, suggesting that the innate immune response and T-cell immunity may be sufficient to eliminate SARS-COV-2.]

Oral Coronavirus Vaccine Candidate Enter Clinical Trial

There have been cases of reinforcement in the Netherlands, Hong Kong, Nevada, Belgium and Ecuador, but only a few have demonstrated a more serious second case. In this case, the researchers stated that the viral genome of the woman’s diagnosis differs at 10 nucleotide positions, and does not contain sequences in the phytolanetic tree. She was also not tested for coronovirus antibodies between her diagnosis, but 4 and 6 days after her second hospitalization, the tests returned negative.

Click here for complete coronary coverage

“Although we did not have PCR negative samples between episodes, with an average estimated SARS-COV-2 mutation rate of 33 nucleotides per year, it is likely that the second episode was a re-infection rather than a prolonged current,” the researchers said. Wrote

Leave a Reply

Your email address will not be published.